Resources

Past Presentation

Emerging Illicit Substances | October 2, 2025

Date of Presentation: October 2, 2025

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder  

Keywords: #kratom  #medetomidine  #nitazenes  #Screening  #stigma  #substance use treatment  #treatment  #xylazine  

In this presentation, Dr. Gregg provides a comprehensive exploration of emerging illicit substances so that attendees can understand the clinical presentation, screening and management of substances such as xylazine, medetomidine, kratom, nitazenes and the street or “designer” benzodiazepines. 

Recording:

Presented by:

Dr. Jessica Gregg
Dr. Jessica Gregg
Lead Faculty

Jessica Gregg, MD, PhD, received her undergraduate degree at Stanford University, her medical degree at the University of New Mexico, and a PhD in Medical Anthropology at Emory University. She began her medical career in primary care at Oregon Health and Science University (OHSU), where she co-founded the OHSU Department of Medicine’s Social Medicine curriculum in partnership with City Central Concern, a non-profit caring for individuals struggling with lack of housing and substance use disorders. She subsequently became the medical director for Central City Concern’s Hooper Detoxification and Stabilization Center, and eventually assumed the role of Senior Medical Director for Substance Use Disorder Services for the agency. She subsequently developed the HRBR clinic at OHSU, a low-threshold buprenorphine clinic, and in 2021, she became Chief Medical Officer for Fora Health in Portland, Oregon.

Read the full bio …

Resources Provided:

Date added: November 30, 2025